Forbion Capital Partners (“Forbion”), one of the leading Dutch Venture Capital firms investing in world-class healthcare technologies, announces its investment inLaboratoris Sanifit S.L. (“Sanifit”), a Spanish clinical-stage biopharmaceutical company, as part of Sanifit’s €36.6M ($41M) Series C financing round.